You can buy or sell ALX Oncology and other stocks, options, and ETFs commission-free!
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. Read More The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA. The listed name for ALXO is ALX Oncology Holdings Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 16, After Hours